BioWorld MedTech

Sep. 14, 2012

Financings roundup: iWalk raises $17 million for personal bionics platform

iWalk (Bedford, Massachusetts) has raised $17 million in a private Series D equity financing round led by Gilde Healthcare Partners. Geoff Pardo, partner at Gilde, has joined iWalk's board. Read More

Report from Israel: The time seems to be right for biomedical clustering in Israel

Sugar, sweat, yeast power new drug delivery device

Washington roundup: Sequestration may not affect device user fee sums in 2013

Agreements/contracts: UW, GE report investment in diagnostic imaging, radiology

Deal roundup: athenahealth to acquire Healthcare Data Services

Restructuring roundup: Ethicon in plan to add new $185M facility in Athens

Patent watch: Solta Medical and BTL resolve patent dispute

Product Briefs

People in the News

HIT roundup: NeoGenomics implements method for FISH test data

MDD's Diagnostic Extra

Today's news in brief

BioWorld

BioWorld briefs for July 10, 2026.

Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy

BioWorld

News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...

FENS 2026: Shedding light on the sheddome

BioWorld

At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...

FENS 2026: Next-gen biologics take on brain disease

BioWorld

Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...

Liver with hepatitis viruses, blood cells

Recombinant vaccine inhibits HBV-associated HCC growth

BioWorld Science

Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....